A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-Tumor Ability in Human Cancer Cells in Vitro and in Vivo
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00205
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 13, 2018
Authors
Publisher
Frontiers Media SA